Allelotype of Pancreatic Adenocarcinoma Using Xenograft Enrichment

Cancer Research

Volumn 55, Issue 20, 1995, Pages 4670-4675

  Hahn, Stephan A ^a   Seymour, Albert B ^a   Hoque, A T M Shamsul ^a   Schutte, Mieke ^a   da Costa, Luis T ^a   Redston, Mark S ^a   Weinstein, Craig L ^a   Fischer, Aryeh ^a   Hruban, Ralph H ^a   Kern, Scott E ^a,a   Caldas, Carlos ^a   Yeo, Charles J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ALLOTYPE; ARTICLE; CHROMOSOME 1P; CHROMOSOME ARM; DNA POLYMORPHISM; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS ADENOCARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; XENOGRAFT;

ADENOCARCINOMA; ALLELES; ANIMAL; CARRIER PROTEINS; CHROMOSOME MAPPING; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; POINT MUTATION; PROTEIN P16; SEQUENCE DELETION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HETEROLOGOUS;

EID: 0028875562     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Boring, C. C., Squires, T. S., and Taong, T. Cancer statistics, 1993. CA Cancer J. Clin., 43: 7–26, 1993.
2. Hraban, R. H., van Mansfeld, A. D. M., Offerhaus, G. J., van Weering D. H. J., Allison, D. C., Goodman, S. N., Kensler, T. W., Bose, K. K., Cameron, J. L., and Bos, J. L. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am. J. Pathol., 143: 545–554, 1993.
3. Almoguerra, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549–554, 1988.
4. Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L. T., Yeo, C. J., and Kern, S. E. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res., 54: 3025–3033, 1994.
5. Pellegata, N. S., Sessa, F., Renault, B., Bonato, M., Leone, B. E., Solcia, E., and Ranzani, G. N. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res., 54: 1556–1560, 1994.
6. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the pl6 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27–32, 1994.
7. Seymour, A. B., Hruban, R. H., Redston, M., Caldas, C., Powell, S. M., Kinzler, K. W., Yee, C. J., and Kern, S. E. Allelotype of pancreatic adenocarcinoma. Cancer Res., 54: 2761–2764, 1994.
8. Pretlow, T. G., Delmoro, C. M., Dilley, G. G., Spadafora, C. G., and Pretlow, T. P. Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res., 51: 3814–3817, 1991.
9. Weber, J. L., and May, P. E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. Hum. Genet., 44: 388–396, 1989.
10. Powell, M. W., Petersen, G. M., Krush, A. J., Booker, S., Jen, J., Giardiello, F. M., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Molecular diagnosis of familial adenomatous polyposis. N. Engl. J. Med., 329: 1982–1987, 1993.
11. Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang, X. K., Demczuk, S., Desmaze, C., Plougastel, B., Pulst, S. M., Lenoir, G., Bijlsma, E., Fashold, R., Dumanski, J., de Jong, P., Parry, D., Eldridge, R., Aurias, A., Delattre, O., and Thomas, G. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature (Lond.), 363: 515–521, 1993.
12. Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., and Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (Lond.), 363: 558–561, 1993.
13. Aaltonen, L. A., Peltomaki, P., Leach, F. S., Sistonen, P., Pylkkanen, L., Mecklin, J. P., Jarvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., Petersen, G. M., Kinzler, K. W., Vogelstein, B., and de la Chapelle, A. Clues to the pathogenesis of familial colorectal cancer. Science (Washington DC), 260: 812–816, 1993.
14. Thibodeau, S. N., Bren, G., and Schaid, D. Microsatellite instability in cancer of the proximal colon. Science (Washington DC), 260: 816–819, 1993.
15. McQueen, H. A., Wyllie, A. H., Puis, J., Foster, E., and Bird, C. C. Stability of critical genetic lesions in human colorectal carcinoma xenografts. Br. J. Cancer, 63: 94–96, 1991.
16. Kern, S. E. Clonality: more than just a tumor-progression model. J. Natl. Cancer Inst., 85: 1020–1021, 1993.
17. Nowell, P. C. The clonal evolution of tumor cell population. Science (Washington DC), 194: 23–28, 1976.
18. Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244: 207–211, 1989.
19. Cliby, W., Ritland, S., Hartmann, L., Dodson, M., Hailing, K. C., Keeney, G., Podratz, K. C., and Jenkins, R. B. Human epithelial ovarian cancer allelotype. Cancer Res., 53: 2393–2398, 1993.
20. Murty, V., Li, R. G., Houldsworth, J., Branson, D. L., Reuter, V. E., Bosl, G. J., and Chaganti, R. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell rumors. Oncogene, 9: 3227–3231, 1994.
21. Shibagaki, I., Shimada, Y., Wagata, T., Ikenaga, M., Imamura, M., and Ishizaki, K. Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res., 54: 2996–3000, 1994.
22. Yamaguchi, T., Toguchida, J., Yamamuro, T., Kotoura, Y., Takada, N., Kawaguchi, N., Kaneko, Y., Nakamura, Y., Sasaki, M. S., and Ishizaki, K. Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res., 52: 2419–2423, 1992.
23. Mitra, A. B., Murty, V., Li, R. G., Pratap, M., Luthra, U. K., and Chaganti, R. Allelotype analysis of cervical carcinoma. Cancer Res., 54: 4481–4487, 1994.
24. Imamura, T., Arima, T., Kato, H., Miyamoto, S., Sasazuki, T., and Wake, N. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas. Int. J. Cancer, 51: 47–52, 1992.
25. Ranzani, G. N., Renault, B., Pellegata, N. S., Fattorini, P., Magni, E., Bacci, F., and Amadori, D. Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum. Genet., 92: 244–249, 1993.
26. Brewster, S. F., Gingell, J. C., Browne, S., and Brown, K. W. Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br. J. Cancer, 70: 697–700, 1994.
27. Gao, X., Honn, K. V., Grignon, D., Sakr, W., and Chen, Y. Q. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res., 53: 2123–2121, 1993.
28. Chenevix, T. G., Leary, J., Kerr, J., Michel, J., Kefford, R., Hurst, T., Parsons, P. G., Friedlander, M., and Khoo, S. K. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene, 7: 1059–1065, 1992.
29. Cho, K. R., Oliner, J. D., Simons, J. W., Hedrick, L., Fearon, E. R., Preisinger, A. C., Hedge, P., Silverman, G. A., and Vogelstein, B. The DCC gene-structural analysis and mutations in colorectal carcinomas. Genomics, 19: 525–531, 1994.
30. Weith, A., Martinsson, T., Cziepluch, C., Briiderlein, S., Amler, L. C., Berthold, F., and Schwab, M. Neuroblastoma consensus deletion maps to lp36.1–2. Genes Chromosomes Cancer, 1: 159–166, 1989.
31. Genuardi, M., Tsihira, H., Anderson, D. E., and Saunders, G. F. Distal deletion of chromosome lp in ductal carcinoma of the breast. Am. J. Hum. Genet., 45: 73–82, 1989.
32. Simon, D., Knowles, B. B., and Weith, A. Abnormalities of chromosome 1 and loss of heterozygosity on lp in primary hepatomas. Oncogene, 6: 765–770, 1991.
33. Bello, M. J., de Campos. J., Kusak, M. E., Vaquero, J., Sarasa, J. L., Pestana, A., and Rey, J. A. Allelic loss at lp is associated with tumor progression of meningiomas. Genes Chromosomes Cancer, 9: 296–298, 1994.
34. Reifenberger, J., Reifenberger, G., Liu, L., James, C. D., Wechsler, W., and Collins, V. P. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and lp. Am. J. Pathol., 145: 1175–1190, 1994.
35. Leister, I., Weith, A., Briiderlein, S., Cziepluch, C., Kangwanpong, D., Schlag, P., and Schwab, M. Human colorectal cancer: high frequency of deletions at chromosome lp35. Cancer Res., 50: 7232–7235, 1990.
36. Mulligan, L. M., Gardner, E., Smith, B. A., Mathew, C. G., and Ponder, B. A. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2. Genes Chromosomes Cancer, 6: 166–177, 1993.
37. Shin, E., Fujita, S., Takami, K., Kurahashi, H., Kurita, Y., Kobayashi, T., Mori, T., Nishisho, I., and Takai, S. Deletion mapping of chromosome lp and 22q in pheo-chromocytoma. Jpn. J. Cancer Res., 84: 402–408, 1993.
38. Mathew, S., Murty, V., Bosl, G. J., and Chaganti, R. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res., 54: 6265–6269, 1994.
39. Griffin, C. A., Hruban, R. H., Long, P. P., Morsberger, L. A., Douna-Issa, F., and Yeo, C. J. Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosomes Cancer, 9: 93–100, 1993.
40. Johansson, B., Bardi, G., Heim, S., Mandahl, N., Mertens, F., Bak-Jensen, E., Andren-Sandberg, L, and Mitelmann, F. Nonrandom chromosomal rearrangements in pancreatic carcinomas. Cancer (Phila.), 69: 1–8, 1992.
41. Bardi, G., Johansson, B., Pandis, N., Mandahl, N., Bak-Jensen, E., Andren-Sandberg, A., Mitelmann, F., and Heim, S. Karyotypic abnormalities in pancreatic adenocarcinoma. Genes Chromosomes Cancer, 67: 1106–1112, 1993.
42. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parson, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817–825, 1993.
43. El-Deiry, W. S., Harper, J. W., Oconnor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y. S., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., EUedge, S. J., Kinzler, K. W., and Vogelstein, B. WAF1/CIP1 is induced in p53-mediated G, arrest and apoptosis. Cancer Res., 54: 1169–1174, 1994.
44. Smith, M. E., Bodmer, J. G., Kelly, A. P., Trowsdale, J., Kirkland, S. C., and Bodmer, W. F. Variation in HLA expression on tumors: an escape from immune response. Cold Spring Harbor Symp. Quant. Biol., 54: 581–586, 1989.
45. Browning, M. J., Krausa, P., Rowan, A., Bicknell, D. C., Bodmer, J. G., and Bodmer, W. F. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc. Natl. Acad. Sci. USA, 90: 2842–2845, 1993.
46. Han, H.-Y., Yanagisawa, A., Kato, Y., Park, J.-G., and Nakamura, Y. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res., 53: 5087–5089, 1993.